Mesoblast (MESO) - 2023 Q1 - Earnings Call Transcript

Mesoblast Limited (NASDAQ:MESO) Q1 2023 Results Conference Call November 22, 2022 4:30 PM ET Company Participants Dr. Silviu Itescu - CEO and MD Andrew Chaponnel - Interim CFO Dr. Eric Rose - Chief Medical Officer Conference Call Participants Carvey Leung - Cantor Fitzgerald Edward Tenthoff - Piper Sandler Dr. Silviu Itescu Good morning, good afternoon to the operational highlights and financial results for the quarter ended September 30, 2022, as well as our upcoming Annual General Meeting. Apologies for t ...